10-Q · February 5, 2026
Azenta reported quarterly revenue of $148,642,000 (reported as 148,642 in the filing) — up modestly from $147,436,000 a year earlier — but reported a GAAP net loss of $15,432,000 (diluted loss per share $0.34). Gross…
Earnings analysis · 10-Q
AZTA earnings analysis
Filed May 8, 2026 · Our reading of the company's report
The latest report
Azenta reported a Q2 FY2026 revenue of $145 million, slightly missing estimates of $148 million. The company's diluted EPS was -$3.49, significantly lower than the expected $0.13, largely impacted by a goodwill…
Read full summary
Azenta reported a Q2 FY2026 revenue of $145 million, slightly missing estimates of $148 million. The company's diluted EPS was -$3.49, significantly lower than the expected $0.13, largely impacted by a goodwill impairment charge of $149 million. Despite some recent revenue growth in segments, management revised down its full-year revenue guidance to a range of $603 to $621 million.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
From revenue to operating profit
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
Where revenue came from
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $-3.49
What stood out
-
Revenue Slightly Misses Estimates
Reported revenue was $145 million, compared to estimates of $148 million.
-
Significant EPS Miss
Diluted EPS was -$3.49, missing analyst expectations of $0.13.
-
Goodwill Impairment Charge
A non-cash goodwill impairment charge of $149 million significantly affected earnings.
-
Segment Revenue Growth
SMS segment revenue grew 1.6% YoY to $81.1 million, while Multiomics grew 0.3% to $63.7 million.
-
Cash Position Remains Strong
Cash and cash equivalents totaled $234 million as of March 31, 2026.
-
Improved Operating Cash Flow
Operating cash inflow was $34.4 million for the six months ended March 31, 2026.
What to watch
-
Failure to Complete B Medical Sale
Thelema has not secured financing for the B Medical Systems acquisition, creating uncertainty.
-
Goodwill and Intangible Assets Impairment
Goodwill impairments of $149.1 million may indicate further financial instability.
-
Increased Operating Expenses
Total operating expenses surged to $227.8 million due to the goodwill impairment.
Management's outlook
Outlook revised down from previous expectations following impairment charges and declining revenue growth.
Earlier filings 4
10-Q · May 9, 2025
Azenta reported quarterly revenue of $143,418,000 (up $7,063,000 or ~5.2% vs. $136,355,000 a year ago) with gross profit of $65,886,000 and a gross margin of ~45.9%. The company remains loss‑making: diluted net loss per…
10-Q · February 10, 2025
Azenta reported quarterly revenue of $147.51 million (three months ended December 31, 2024) versus $141.73 million a year ago, with gross profit rising to $68.671 million. Operating loss narrowed to $(11.353) million…
10-Q · August 6, 2024
Azenta reported Q3 revenue of $172.809M, up $6.861M (4.1%) versus $165.948M a year ago, with gross profit of $69.056M (up $1.051M). Operating loss improved to $(14.754)M from $(15.836)M a year ago, but the company…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.